HealthCare.com key facts
as of Oct 2026- Provider of health insurance comparison services intended to find, compare, and buy insurance that best fits one's needs.
- HealthCare.com is valued at approximately $1.0B as of Oct 2026 (last reported valuation).
- It has raised $246.8M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Interplay Ventures, Link Ventures, Invariantes Fund, Annox Capital, Oaktree Capital Management — 17 tracked in total.
- Status: Privately Held (backing).
HealthCare.com's last reported valuation, Feb 2022. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch HealthCare.com: the Monday email on marks, rounds and moves
HealthCare.com funding rounds
No funding rounds for HealthCare.com are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs HealthCare.com
17+HealthCare.com valuation
HealthCare.com's last reported valuation was $1 billion in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.
HealthCare.com investors
17 investors are on record for HealthCare.com, including Interplay Ventures, Link Ventures, Invariantes Fund and Annox Capital.
About HealthCare.com
Provider of health insurance comparison services intended to find, compare, and buy insurance that best fits one's needs. The company offers a platform augmented by various artificial intelligence and machine learning approaches to provide more personalized user experiences, and its services include a search destination that compares and recommends healthcare products and services, and offers expert advice, data, and options to consumers, enabling customers in need of health insurance to make well-informed decisions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Miami, FL, United States
- Founded
- 2014
- Employees
- 216
- Website
- healthcare.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.